Classification of motility stimulants
Drugs that enhance gastrointestinal motility are divided into several main groups depending on the receptors they act upon.
- M-cholinomimetics (bethanechol) and anticholinesterase agents (neostigmine methylsulfate). These drugs are called cholinergic. Currently, they are rarely used in clinical practice. The main reason for abandoning their widespread use is that they increase overall smooth muscle tone without providing sufficient propulsive activity required for normal digestion.
- Dopamine D2-receptor antagonists. This group includes classical prokinetics: metoclopramide and domperidone.
- Serotonin 5-HT4 receptor agonists (serotonergic agents). Representatives of this group include tegaserod and cisapride.
Dopamine D2-receptor antagonists
Normally, the neurotransmitter dopamine inhibits acetylcholine release in the gastrointestinal nerve ganglia. Prokinetics of this group block D2 receptors, thereby removing this inhibition. As a result, acetylcholine release increases, leading to stimulation of the propulsive activity of the stomach and intestines.
Metoclopramide has a complex mechanism of action. In addition to its primary antidopaminergic effect (D2-receptor blockade), it stimulates serotonin 5-HT4 receptors and blocks 5-HT3 receptors. The drug predominantly affects the upper gastrointestinal tract.
- Indications: The main application is the relief of nausea and vomiting caused by gastric motility disorders. It is less commonly used for gastroesophageal reflux disease (GERD).
- Side effects: Metoclopramide readily crosses the blood-brain barrier (BBB). Blockade of dopamine receptors in the central nervous system causes dangerous extrapyramidal disorders. The drug can also cause galactorrhea due to hormonal imbalances.
Domperidone also blocks D2 receptors, which determines its prokinetic activity. However, its most important pharmacokinetic feature is that it practically does not cross the BBB. The clinical significance of this fact is enormous: unlike metoclopramide, domperidone practically does not cause central side effects.
Serotonergic prokinetics
This group of drugs acts on serotonin receptors to stimulate motility. However, their use is severely limited due to cardiovascular side effects.
Tegaserod is a partial 5-HT4 receptor agonist. Its mechanism of action is associated with the activation of intrinsic primary afferent neurons, which stimulates acetylcholine release and leads to increased intestinal motility. The drug stimulates motility throughout the entire GI tract: from the esophagus and stomach to the small intestine and ascending colon. The main indication is irritable bowel syndrome. The main limitation to its use is a pronounced arrhythmogenic effect.
Cisapride stimulates 5-HT4 receptors and simultaneously blocks 5-HT3 receptors. Historically, it was widely used to treat gastroparesis and reflux disease. Currently, its use is strictly limited due to the high risk of cardiac complications. Cisapride can cause ventricular fibrillation and specific torsades de pointes arrhythmia.
Briefly: answers to topical questions
What side effects are characteristic of metoclopramide?
Metoclopramide is characterized by side effects affecting the central nervous, endocrine, and digestive systems.
- Neurological — extrapyramidal disorders resulting from the drug crossing the blood-brain barrier and blocking dopamine in the CNS.
- Endocrine — galactorrhea, hyperprolactinemia, amenorrhea, and gynecomastia (developing due to systemic dopamine blockade).
- Gastrointestinal — diarrhea and flatulence.
What are the absolute contraindications to prescribing metoclopramide?
Contraindications to prescribing metoclopramide include:
- Gastrointestinal bleeding.
- GI perforation.
- Muscle dyskinesia induced by neuroleptics.
- Breastfeeding period.
What is the mechanism of the prokinetic action of macrolides (e.g., erythromycin)?
The mechanism of the prokinetic action of macrolides, specifically erythromycin, lies in the direct stimulation of gastrointestinal motility. The drug possesses intrinsic prokinetic activity, leading to accelerated gastric emptying. Due to this effect, erythromycin is used as a fast-acting prokinetic for emergency preparation of the upper GI tract for endoscopic examinations (e.g., in gastrointestinal bleeding to clear the lumen of clots).
What is the mechanism of action of itopride?
The mechanism of action of itopride is based on two effects:
- Dopamine receptor antagonism.
- Acetylcholinesterase blockade.
As a result, itopride activates acetylcholine release and prevents its degradation. In GERD, it normalizes the motor function of the upper GI tract and reduces the number of transient lower esophageal sphincter relaxations. In combination with proton pump inhibitors, it reliably enhances lower esophageal sphincter contractility and gastric motility, accelerates gastric emptying, and restores gastroduodenal coordination.
To remember the difference between D2-receptor blockers, use the phrase: "Metoclopramide Targets the Mind (crosses the BBB), while Domperidone Stays at Home (does not cross the BBB and acts peripherally)."
Class and exam questions
Why are cholinergic agents rarely used as prokinetics?
M-cholinomimetics and anticholinesterase agents increase GI smooth muscle tone but do not provide sufficient propulsive activity.
What is the main difference between domperidone and metoclopramide?
Both drugs block D2 receptors, but domperidone does not cross the blood-brain barrier and therefore does not cause central side effects (extrapyramidal disorders).
Why has cisapride practically ceased to be used clinically?
Due to the high risk of severe cardiac complications, including ventricular fibrillation and torsades de pointes.
What else to study on this topic
- Mechanisms of extrapyramidal disorders development during dopamine receptor blockade in the central nervous system.
- Pathogenetic features of gastroesophageal reflux disease (GERD) and the role of motility.
- Torsades de pointes: causes and association with QT interval prolongation.
- Relationship between dopamine and prolactin: mechanism of galactorrhea development during metoclopramide administration.
- The role of primary afferent neurons in the regulation of intestinal motility.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Prokinetics» and 5,304 more pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section «Drugs Affecting Digestive System Functions»
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.